Abstract
T2DM is today considered as world-wide health problem, with complications responsible of an enhanced mortality and morbidity. Thus, new strategies for its prevention and therapy are necessary. For this reason, the research interest has focused its attention on TLR4 and its polymorphisms, particularly the rs4986790. However, no conclusive findings have been reported until now about the role of this polymorphism in development of T2DM and its complications, even if a recent meta-analysis showed its T2DM association in Caucasians. In this study, we sought to evaluate the weight of rs4986790 polymorphism in the risk of the major T2DM complications, including 367 T2DM patients complicated for the 55.6%. Patients with A/A and A/G TLR4 genotypes showed significant differences in complication's prevalence. In particular, AG carriers had higher risk prevalence for neuropathy (P = 0.026), lower limb arteriopathy (P = 0.013), and the major cardiovascular pathologies (P = 0.017). Their cumulative risk was significant (P = 0.01), with a threefold risk to develop neuropathy, lower limb arteriopathy, and major cardiovascular events in AG cases compared to AA cases. The adjusted OR for the confounding variables was 3.788 (95% CI: 1.642-8.741). Thus, the rs4986790 polymorphism may be an indicative of prevalence of complications in T2DM patients.
| Original language | English |
|---|---|
| Article number | 973139 |
| Journal | Mediators of Inflammation |
| Volume | 2014 |
| DOIs | |
| Publication status | Published - 2014 |
Fingerprint
ASJC Scopus subject areas
- Immunology
- Cell Biology
- Medicine(all)
Cite this
Evidences of +896 A/G TLR4 polymorphism as an indicative of prevalence of complications in T2DM patients. / Balistreri, Carmela Rita; Bonfigli, Anna Rita; Boemi, Massimo; Olivieri, Fabiola; Ceriello, Antonio; Genovese, Stefano; Franceschi, Claudio; Spazzafumo, Liana; Fabietti, Paolo; Candore, Giuseppina; Caruso, Calogero; Lio, Domenico; Testa, Roberto.
In: Mediators of Inflammation, Vol. 2014, 973139, 2014.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Evidences of +896 A/G TLR4 polymorphism as an indicative of prevalence of complications in T2DM patients
AU - Balistreri, Carmela Rita
AU - Bonfigli, Anna Rita
AU - Boemi, Massimo
AU - Olivieri, Fabiola
AU - Ceriello, Antonio
AU - Genovese, Stefano
AU - Franceschi, Claudio
AU - Spazzafumo, Liana
AU - Fabietti, Paolo
AU - Candore, Giuseppina
AU - Caruso, Calogero
AU - Lio, Domenico
AU - Testa, Roberto
PY - 2014
Y1 - 2014
N2 - T2DM is today considered as world-wide health problem, with complications responsible of an enhanced mortality and morbidity. Thus, new strategies for its prevention and therapy are necessary. For this reason, the research interest has focused its attention on TLR4 and its polymorphisms, particularly the rs4986790. However, no conclusive findings have been reported until now about the role of this polymorphism in development of T2DM and its complications, even if a recent meta-analysis showed its T2DM association in Caucasians. In this study, we sought to evaluate the weight of rs4986790 polymorphism in the risk of the major T2DM complications, including 367 T2DM patients complicated for the 55.6%. Patients with A/A and A/G TLR4 genotypes showed significant differences in complication's prevalence. In particular, AG carriers had higher risk prevalence for neuropathy (P = 0.026), lower limb arteriopathy (P = 0.013), and the major cardiovascular pathologies (P = 0.017). Their cumulative risk was significant (P = 0.01), with a threefold risk to develop neuropathy, lower limb arteriopathy, and major cardiovascular events in AG cases compared to AA cases. The adjusted OR for the confounding variables was 3.788 (95% CI: 1.642-8.741). Thus, the rs4986790 polymorphism may be an indicative of prevalence of complications in T2DM patients.
AB - T2DM is today considered as world-wide health problem, with complications responsible of an enhanced mortality and morbidity. Thus, new strategies for its prevention and therapy are necessary. For this reason, the research interest has focused its attention on TLR4 and its polymorphisms, particularly the rs4986790. However, no conclusive findings have been reported until now about the role of this polymorphism in development of T2DM and its complications, even if a recent meta-analysis showed its T2DM association in Caucasians. In this study, we sought to evaluate the weight of rs4986790 polymorphism in the risk of the major T2DM complications, including 367 T2DM patients complicated for the 55.6%. Patients with A/A and A/G TLR4 genotypes showed significant differences in complication's prevalence. In particular, AG carriers had higher risk prevalence for neuropathy (P = 0.026), lower limb arteriopathy (P = 0.013), and the major cardiovascular pathologies (P = 0.017). Their cumulative risk was significant (P = 0.01), with a threefold risk to develop neuropathy, lower limb arteriopathy, and major cardiovascular events in AG cases compared to AA cases. The adjusted OR for the confounding variables was 3.788 (95% CI: 1.642-8.741). Thus, the rs4986790 polymorphism may be an indicative of prevalence of complications in T2DM patients.
UR - http://www.scopus.com/inward/record.url?scp=84899479667&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84899479667&partnerID=8YFLogxK
U2 - 10.1155/2014/973139
DO - 10.1155/2014/973139
M3 - Article
C2 - 24803744
AN - SCOPUS:84899479667
VL - 2014
JO - Mediators of Inflammation
JF - Mediators of Inflammation
SN - 0962-9351
M1 - 973139
ER -